As a regular addition to the diet, brown rice can help reduce body weight, lower cholesterol, and suppress inflammation.

Caffeine, polyphenols, and other natural products found in coffee may help reduce the severity of non-alcoholic fatty liver disease

Researchers have discovered that those who have a certain version of a gene involved in cell nutrition tend to accumulate less fat.

People with obesity treated with a weekly dose of Tirzepatide lost about 52 pounds on average, according to results of a new study.

People with obesity treated with a weekly dose of a new pill lost about 52 pounds on average, according to results of a new study.

Researchers discovered that those who have a certain version of a gene involved in cell nutrition tend to accumulate less fat.

Recently approved by the FDA to treat type 2 diabetes, the medication may help adults without diabetes lose weight as well, the study found

A new drug which is approved for adults with obesity or overweight, also helps adolescents shed pounds and have healthier hearts.

Visceral fat is often dubbed the ‘hidden' fat because it lies in the body's midsection, where it can't be touched or seen.

Twenty-one patients with metabolic syndrome were given a calorie or protein restriction diet in a randomized clinical trial by researchers.

In recent years, researchers have extensively examined which genes and gene variants play a role in excess weight.

The study included 2,539 participants with obesity who were randomized to receive placebo, tirzepatide 5 mg, 10 mg or 15 mg for 72 weeks.

A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet.

Women with a history of diabetes in pregnancy can still reduce their chances of developing type 2 diabetes by adopting a healthy lifestyle

Drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity, and improves heart function.

The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research.

Scientists identified two distinct types of obesity with physiological and molecular differences that have lifelong consequences for health.

People with obesity treated with a weekly dose of Tirzepatide, a novel GIP/GLP-1 receptor agonist lost about 52 pounds on average.

Weight gain can be prevented and perhaps reversed — even during a pandemic — with the help and support of a person's community.

People with obesity treated with a weekly dose of Tirzepatide, lost about 52 pounds on average, according to results of a new study.